[Cyclic GMP as a biomarker for cardiovascular disease and cancer].

Background: Levels of cyclic guanosine 3',5'-monophosphate (cGMP) are elevated in plasma and urine from patients with some cardiovascular diseases and some types of cancer.

Materials And Methods: This paper is based on studies of cGMP as a biomarker.

Results And Interpretation: It is well documented that cGMP levels are elevated in plasma in patients with heart failure and various leukaemias and in urine from patients with gynaecological cancers.